OSM Industry Intel • Summer 2026 The Brain’s Immune Cells Get Stuck in Attack Mode. The Fix Is Not More Antioxidant. It Is the Right Amount. A new Frontiers in Nutrition review reframes neuroprotection around microglial immune state and a dose-response curve that is shaped like an upside-down U. The implication for formulators is uncomfortable […]
Learn More
OSM Industry Intel • Spring 2026 L-Theanine Has Been Sold as a 30-Minute Ingredient. New Research Says It Is Also Doing Something Much Slower. A new study traces L-theanine’s effects on mood through an unexpected route: the gut microbiome. It reshaped bacterial populations, boosted short-chain fatty acid production, and calmed the same inflammatory pathway in […]
Learn More
OSM Industry Intel • Spring 2026 The NIH Just Tested 8 Longevity Compounds. All 8 Failed. The Reason Should Change How You Formulate. The gold-standard longevity screen posted a clean sweep of nulls in 2026, including a compound that passed the same test three years ago. The dose gap between those two results is the […]
Learn More
OSM Industry Intel • Spring 2026 Brain Fog Might Be a Fuel Delivery Problem. Here Is the Metabolic Workaround Brands Should Watch. A January 2026 review lays out how the aging or insulin-resistant brain slowly loses its ability to burn glucose, and how alternative fuels like ketones may sidestep the broken machinery entirely. Here is […]
Learn More
OSM Industry Intel • Spring 2026 Science Just Found the Cellular “Toxic Waste Leak” Behind Inflammaging. Here Is the Supplement Angle. A 2025 review pulls together a striking discovery: aging immune cells lose the ability to take out their own cellular trash, then leak mitochondrial DNA that the body mistakes for a viral invasion. The […]
Learn More